RNA editing plays a critical role in the expression of certain gene products by changing the coding sequences of mRNA's, which results in the synthesis of proteins not directly encoded in the genome. One type of RNA editing involves a conversion of adenosine residues into inosine in transcripts of important mammalian genes such as glutamate receptors (GluR), ion channels and 5-HT serotonin receptors. It is assumed that there are many other target RNAs that are yet to be identified. The overall goal of this project is to elucidate the molecular mechanisms of A to I RNA editing and better understand its biological significance. With the support provided by this grant over the past 7 years, we have cloned for the first time, ADAR I, the first member of the dsRNA adenosine gene family, which led to identification and cloning of the second and third members, ADAR2 and ADAR3. We and others have demonstrated that these recombinantly expressed deaminases can indeed execute or modulate the site selective A-to-I editing of GluR and 5-HT2cR RNAs in vitro. We now propose to: 1) Investigate the mechanism of the editing site selectivity displayed by the different ADAR gene family members. 2) Investigate the possible activation mechanism of ADAR3, the newest member of the gene family and latent form enzyme. 3) Search for new additional members of the ADAR gene family and test their editing site selectivity 4) Identify new target RNAs/genes for A-to-I RNA editing. The information gained from the proposed experiments will allow us to better understand this intriguing RNA editing system and its role in the regulation of target gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM040536-13
Application #
6635983
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Rhoades, Marcus M
Project Start
1991-07-01
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2005-03-31
Support Year
13
Fiscal Year
2003
Total Cost
$297,539
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sakurai, Masayuki; Shiromoto, Yusuke; Ota, Hiromitsu et al. (2017) ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay. Nat Struct Mol Biol 24:534-543
Tan, Meng How; Li, Qin; Shanmugam, Raghuvaran et al. (2017) Dynamic landscape and regulation of RNA editing in mammals. Nature 550:249-254
Nishikura, Kazuko (2017) Oesophageal cancer: RNA editing of SLC22A3 mRNAs: causative relevance to familial ESCC? Nat Rev Gastroenterol Hepatol 14:569-570
Song, Chunzi; Sakurai, Masayuki; Shiromoto, Yusuke et al. (2016) Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases. Genes (Basel) 7:
Miyake, Kotaro; Ohta, Toshio; Nakayama, Hisako et al. (2016) CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis. Cell Rep 17:2004-2014
Nishikura, Kazuko (2016) A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol 17:83-96
Gumireddy, Kiranmai; Li, Anping; Kossenkov, Andrew V et al. (2016) The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat Commun 7:10715
Watanabe, Yoshihisa; Yoshimoto, Kanji; Tatebe, Harutsugu et al. (2014) Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors. Int J Neuropsychopharmacol 17:739-51
Ota, Hiromitsu; Sakurai, Masayuki; Gupta, Ravi et al. (2013) ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153:575-89
Nishikura, Kazuko; Sakurai, Masayuki; Ariyoshi, Kantaro et al. (2013) Antagonistic and stimulative roles of ADAR1 in RNA silencing. RNA Biol 10:1240-7

Showing the most recent 10 out of 37 publications